StockData
Twist Bioscience Corp logo

Twist Bioscience Corp (TWST) stock

TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Nov 16, 2026Score 13/30207% above fair value
$112.00+6.96 (+6.63%)

Close on Nov 17, 2026Market cap $7.02BP/E –Yield –

Twist Bioscience price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Twist Bioscience's price to sales ratio was 17.8× on Nov 11, 2026, against 5.2× a year earlier. Over the last 5 years it ranged from 3.3× to 28.9×, with a median of 8.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202617.8×+12.7
2025Dec 31, 20255.1×−3.6
2024Dec 31, 20248.7×+0.1
2023Dec 29, 20238.7×+2.0
2022Dec 30, 20226.6×−22.3
2021Dec 31, 202128.9×−41.7
2020Dec 31, 202070.7×+58.0
2019Dec 31, 201912.7×+9.8
2018Dec 31, 20182.9×–

More Twist Bioscience figures

See a number that looks wrong?